Papillary thyroid cancer (PTC) is the most common type of thyroid cancer (85–90%)[1]. In
2020, the European Network of Cancer Registries reported approximately 57 709 cases of …

We analyzed miR-146b, miR-21, miR-221, miR-21, and miR-181b in formalin fixed paraffin-
embedded papillary thyroid carcinoma (PTC) tissue samples of 312 individuals and …

In recent years, the global incidence of thyroid cancer has been increasing. Despite the
significant progress in the diagnostic tools applied for papillary thyroid cancer (PTC) …

Objectives The microRNAs (miRNAs) are known to be commonly expressed in papillary
thyroid carcinoma. The BRAF V600E mutation is the most common genetic mutation in …

Objectives: The microRNAs (miRNAs) are known to be commonly expressed in papillary
thyroid carcinoma. The BRAFV600E mutation is the most common genetic mutation in …

QIU, Jie et al. Identification of key genes and miRNAs markers of papillary thyroid cancer.
Biol. Res.[online]. 2018, vol. 51, 45. Epub 28-Nov-2018. ISSN 0716-9760. http://dx. doi …

Patients were designated as having highrisk (≥ 45 years old with stage i or ii PtC) or low-
risk (< 45 years old with stage i PtC) cancer. the findings revealed associations between …

Introduction Papillary thyroid cancer (PTC) accounts for up to 80% of thyroid malignancies.
New diagnostic and therapeutic options are suggested including innovative molecular …

Background Detection of cancer in patients with thyroid nodules requires sensitive and
specific diagnostic modalities that are accurate and inexpensive. This study aimed to identify …

Background: Papillary thyroid carcinoma (PTC) are clinicopathogenetically heterogeneous.
Micro-RNAs (miRNAs) are involved in the pathogenesis of diverse human cancers …